Discovery and Optimization of Novel Small-molecular Inhibitors Suppressing Stat3-dependent Tumor Process
Xiaolei Zhang(Nanjing Medical University)
Journal of International Crisis and Risk Communication Research
January 1, 2011
Cited by 0
Related Papers
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
|Proceedings of the National Academy of Sciences|2012|347
ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner
|Annals of Translational Medicine|2020|105
The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts
|Acta Pharmacologica Sinica|2021|35
<p>Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo</p>
|OncoTargets and Therapy|2020|9